BioSpace News Archive

ONCOtherapeutics and Dr. James Berenson published promising new data demonstrating that ruxolitinib (RUX), an oral JAK1/2 inhibitor, with only methylprednisolone (MP) well tolerated and shows efficacy for treating heavily previously treated multiple myeloma (MM) patients.

Phoenix Children’s, one of the nation’s fastest-growing pediatric health systems, has announced the creation of a new Division of Anesthesiology and named Dr. Narasimhan “Sim” Jagannathan as Division Chief and Dr. Amod Sawardekar as Associate Division Chief.

Stereotaxis announced the successful treatment of patients using the latest Genesis Robotic Magnetic Navigation system by physicians of the nationally recognized Fred & Lena Meijer Heart Center, part of Corewell Health in Grand Rapids, Michigan.

Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced it has received an additional FDA approval for treatment of essential tremor using its Exablate Neuro platform.

March of Dimes, the leading organization fighting for the health of moms and babies, is pleased to announce Patricia Hunt, PhD as the recipient of the 2022 Richard B. Johnston, Jr., MD Prize in Developmental Biology.

Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder), a novel investigational therapeutic product candidate for the acute treatment of migraine, today provided an update on its STS101 development program and corporate update.

Mizuho OSI®, a leading manufacturer of specialty surgical tables and pressure injury abatement solutions has been recognized by The California Council for Excellence as one of only three silver level recipients of the California Awards for Performance Excellence.

Presbyterian Medical Services is an FQHC that delivers integrated healthcare, education, and services to address the needs of diverse communities across the Southwest, with a specific focus on Native American populations.

Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of H. Stewart Parker to its Board of Directors.

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 11:15am PT / 2:15pm ET.